Cited by

• MicroRNA Profiling from Tears as a Potential Non-invasive Method for Early Detection of Diabetic Retinopathy.

  Wong WKM, Polkamp M, Farr RJ, Kunte PS, Hardikar HP, Yajnik CS, Hardikar AA, Joglekar MV. Wong WKM, et al. Methods Mol Biol. 2023;2678:117-134. doi: 10.1007/978-1-0716-3255-0_8. Methods Mol Biol. 2023. PMID: 37326708
• The link between glycemic control measures and eye microvascular complications in a clinical cohort of type 2 diabetes with microRNA-223-3p signature.

  Da'as SI, Ahmed I, Hasan WH, Abdelrahman DA, Aliyev E, Nisar S, Bhat AA, Joglekar MV, Hardikar AA, Fakhro KA, Akil ASA. Da'as SI, et al. J Transl Med. 2023 Mar 3;21(1):171. doi: 10.1186/s12967-023-03893-2. J Transl Med. 2023. PMID: 36869348 Free PMC article.
• Diabetic Retinopathy: Soluble and Imaging Ocular Biomarkers.

  Ferrara M, Loda A, Coco G, Grassi P, Cestaro S, Rezzola S, Romano V, Semeraro F. Ferrara M, et al. J Clin Med. 2023 Jan 24;12(3):912. doi: 10.3390/jcm12030912. J Clin Med. 2023. PMID: 36769560 Free PMC article. Review.
• MicroRNA-150 (miR-150) and Diabetic Retinopathy: Is miR-150 Only a Biomarker or Does It Contribute to Disease Progression?

  Ko GY, Yu F, Bayless KJ, Ko ML. Ko GY, et al. Int J Mol Sci. 2022 Oct 11;23(20):12099. doi: 10.3390/ijms232012099. Int J Mol Sci. 2022. PMID: 36292956 Free PMC article. Review.
• miR-145, miR-92a and miR-375 Show Differential Expression in Serum from Patients with Diabetic Retinopathies.

  Solis-Vivanco A, Santamaría-Olmedo M, Rodríguez-Juárez D, Valdés-Flores M, González-Castor C, Velázquez-Cruz R, Ramírez-Salazar E, García-Ulloa AC, Hidalgo-Bravo A. Solis-Vivanco A, et al. Diagnostics (Basel). 2022 Sep 21;12(10):2275. doi: 10.3390/diagnostics12102275. Diagnostics (Basel). 2022. PMID: 36291965 Free PMC article.